“Retirement Secret” Showed 995% Gain Last Time We Shared It

Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.

Find out why right here (and see what you can do to get in too with just a few dollars).

Zachary William Stassen net worth and biography

Zachary Stassen Biography and Net Worth

CFO of ViewRay

Zach has more than 20 years of experience in the medical device and healthcare industries. He was most recently the CFO and COO at Bolder Surgical, an innovative, privately-held med-tech company. Prior to Bolder Surgical, Zach held various business development roles at Spectranetics, including Vice President of Finance, prior to its acquisition by Royal Philips. Earlier, he co-founded a device company that was acquired by Cardinal Health. Zach also has experience as a healthcare investment banker on Piper Jaffray’s team. He holds an MBA from the Kellogg School of Management at Northwestern and a bachelor’s degree from Drake University.

What is Zachary William Stassen's net worth?: The estimated net worth of Zachary William Stassen is at least $0.00 as of May 10th, 2022. Mr. Stassen owns 636,363 shares of ViewRay stock worth more than $0 as of April 26th. This net worth approximation does not reflect any other investments that Mr. Stassen may own. Learn More about Zachary William Stassen's net worth.
How do I contact Zachary William Stassen?: The corporate mailing address for Mr. Stassen and other ViewRay executives is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. ViewRay can also be reached via phone at (440) 703-3210 and via email at [email protected]. Learn More on Zachary William Stassen's contact information.
Has Zachary William Stassen been buying or selling shares of ViewRay?: Zachary William Stassen has not been actively trading shares of ViewRay during the last quarter. Most recently, on Tuesday, May 10th, Zachary William Stassen bought 100,000 shares of ViewRay stock. The stock was acquired at an average cost of $2.68 per share, with a total value of $268,000.00. Following the completion of the transaction, the chief financial officer now directly owns 636,363 shares of the company's stock, valued at $1,705,452.84. Learn More on Zachary William Stassen's trading history.
Who are ViewRay's active insiders?: ViewRay's insider roster includes Scott Drake (CEO), and Zachary Stassen (CFO). Learn More on ViewRay's active insiders.
Are insiders buying or selling shares of ViewRay?: During the last twelve months, insiders at the sold shares 6 times. They sold a total of 8,610,882 shares worth more than $519,973.64. The most recent insider tranaction occured on July, 21st when Director Karen Prange sold 37,600 shares worth more than $1,880.00. Insiders at ViewRay own 2.5% of the company. Learn More about insider trades at ViewRay.
Information on this page was last updated on 7/21/2023.

Zachary William Stassen Insider Trading History at ViewRay

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/10/2022	Buy	100,000	$2.68	$268,000.00	636,363
11/19/2021	Buy	17,857	$5.60	$99,999.20
8/24/2021	Buy	40,000	$5.32	$212,800.00

Zachary William Stassen Buying and Selling Activity at ViewRay

ViewRay Company Overview

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, Italy, France, Taiwan, the United Kingdom, and internationally. It provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers through a network of direct sales force and distributors. ViewRay, Inc. was founded in 2004 and is headquartered in Denver, Colorado.

Today's Range

Now: N/A

50 Day Range

MA: $0.34

$0.03

$0.65

2 Week Range

Now: N/A

Volume

108,502,700 shs

Average Volume

7,510,055 shs

Market Capitalization

$4.59 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.81